Xvivo Perfusion AB logo

Xvivo Perfusion AB

STU:3XV (Sweden)  
€ 23.80 (+0.21%) Mar 27
343.83
P/B:
4.55
Market Cap:
€ 754.96M ($ 817.03M)
Enterprise V:
€ 705.39M ($ 763.39M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 23.28
Equity-to-Asset 0.86
Debt-to-Equity 0.01
Debt-to-EBITDA 0.65
Interest Coverage 1.1
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.79
Distress
Grey
Safe
Beneish M-Score -2.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.16
9-Day RSI 42.8
14-Day RSI 44.71
6-1 Month Momentum % -1.47
12-1 Month Momentum % 12.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.15
Quick Ratio 5.12
Cash Ratio 4.18
Days Inventory 279.42
Days Sales Outstanding 76.19
Days Payable 93.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -0.95

Financials (Next Earnings Date:2024-04-24)

STU:3XV's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Xvivo Perfusion AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 50.14
EPS (TTM) (€) 0.072
Beta 2.72
Volatility % 53.14
14-Day RSI 44.71
14-Day ATR (€) 0.574927
20-Day SMA (€) 24.5325
12-1 Month Momentum % 12.2
52-Week Range (€) 18.52 - 30.2
Shares Outstanding (Mil) 31.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Xvivo Perfusion AB Filings

Filing Date Document Date Form
No Filing Data

Xvivo Perfusion AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Xvivo Perfusion AB Frequently Asked Questions

What is Xvivo Perfusion AB(STU:3XV)'s stock price today?
The current price of STU:3XV is €23.80. The 52 week high of STU:3XV is €30.20 and 52 week low is €18.52.
When is next earnings date of Xvivo Perfusion AB(STU:3XV)?
The next earnings date of Xvivo Perfusion AB(STU:3XV) is 2024-04-24.
Does Xvivo Perfusion AB(STU:3XV) pay dividends? If so, how much?
Xvivo Perfusion AB(STU:3XV) does not pay dividend.

Press Release

Subject Date
No Press Release